Microarray based mRNA profiling was used to charactarize and compare the gene expression in cells grown as monolayer or spheroids.
Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Cell line
View SamplesTranscriptional expression data for bioactive small molecules for mechanism identification.
Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters.
No sample metadata fields
View SamplesMicroarray based mRNA profiling was used to identify the mechanism of action for the small molecule VLX60.
Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.
Cell line
View SamplesMicroarray based mRNA profiling was used to identify the mechanism of action for the small molecule b-AP15.
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
Cell line, Treatment
View SamplesPrimary cultures of patient tumor cells (PCPTC) were used in a cell-based cytotoxicity screen. Microarray-based mRNA profiling was used to identify the mechanism-of-action for the small molecule VLX 50.
Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment.
Specimen part, Disease, Cell line, Treatment
View SamplesMicroarray based mRNA profiling was used to identify the mechanism of action for the small molecule VLX600.
Iron chelators target both proliferating and quiescent cancer cells.
Disease, Cell line, Treatment
View SamplesThis SuperSeries is composed of the SubSeries listed below.
Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
Specimen part
View SamplesThe cell of origin in glioblastoma is not formally proven but generally accepted to be a neural stem cell or glial precursor cell. In addition, there is also limited knowledge about the functional consequences of the cell of origin for glioblastoma development and response to therapy.
Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
Specimen part
View SamplesThe cell of origin in glioblastoma is not formally proven but generally accepted to be a neural stem cell or glial precursor cell. In addition, there is also limited knowledge about the functional consequences of the cell of origin for glioblastoma development and response to therapy.
Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
Specimen part
View SamplesMicroarray based mRNA profiling was used to charactarize and compare the gene expression in cells grown as monolayer or spheroids.
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.
Cell line
View Samples